CStone Pharmaceuticals Eulerpool Novinky

CStone Pharmaceuticals Eulerpool News

CStone Pharmaceuticals Novinky o akciích

CStone Pharmaceuticals je sledován mnoha novináři a investory po celém světě. Nejaktuálnější CStone Pharmaceuticals zprávy shromažďujeme zde.

• 30. září ·

  Yahoo
  High Growth Tech Stocks In Hong Kong To Watch This September 2024
• 2. září ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring SUNeVision Holdings And Two Others
• 23. srpna ·

  Yahoo
  CStone Reports 2024 Interim Results and Recent Corporate Updates
• 26. července ·

  Yahoo
  CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
• 2. června ·

  SeekingAlpha
  Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
• 2. června ·

  Yahoo
  CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
• 26. května ·

  SeekingAlpha
  Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
• 24. května ·

  Yahoo
  CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website
• 27. března ·

  Yahoo
  CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
• 15. března ·

  Yahoo
  CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer